From: Prognostic impact of PTK6 expression in triple negative breast cancer
Clinicopathologic features | LNM +  | P | LNM- | P | ||
---|---|---|---|---|---|---|
- |  +  | - |  +  | |||
Histological type | Â | Â | 0.451b | Â | Â | 0.498a |
 IDC | 20 | 65 |  | 54 | 19 |  |
 Other types | 2 | 15 |  | 23 | 11 |  |
Age(y) | Â | Â | 0.368a | Â | Â | 0.155a |
  ≥ 50 | 10 | 45 |  | 40 | 11 |  |
  < 50 | 12 | 35 |  | 37 | 19 |  |
Site | Â | Â | 0.656a | Â | Â | 0.427a |
 Left breast | 13 | 43 |  | 50 | 17 |  |
 Right breast | 9 | 37 |  | 27 | 13 |  |
Histological grading | Â | Â | 0.308c | Â | Â | 0.312c |
 I | 1 | 0 |  | 0 | 0 |  |
 II | 6 | 25 |  | 30 | 20 |  |
 III | 15 | 55 |  | 40 | 17 |  |
T stage | Â | Â | 0.416b | Â | Â | 0.181b |
 T1-T2 | 21 | 69 |  | 74 | 26 |  |
 T3-T4 | 1 | 11 |  | 3 | 4 |  |
N stage | Â | Â | 0.322b | Â | Â | N |
 N1 | 16 | 49 |  | N | N |  |
 N2 | 4 | 12 |  | N | N |  |
 N3 | 2 | 19 |  | N | N |  |
HER2 | Â | Â | 0.917a | Â | Â | 0.711a |
 N | 11 | 39 |  | 38 | 16 |  |
 L | 11 | 41 |  | 39 | 14 |  |
D or R | Â | Â | 0.078b | Â | Â | 1b |
 Yes | 3 | 29 |  | 8 | 3 |  |
 No | 19 | 51 |  | 69 | 27 |  |
Survival time(y) | Â | Â | 0.018c | Â | Â | Nc |
  < 5 | 0 | 15 |  | 0 | 0 |  |
  ≥ 5 | 22 | 55 |  | 79 | 30 |  |